Association of 4G/5G polymorphism in PAI1 promoter with PAI1 level in deep vein thrombosis

Chinese Journal of Medical Genetics

Volumn 22, Issue 6, 2005, Pages 624-627

  Chen, Yong Li ^a   Zhang, Jing Xia ^b   Wang, Pei Xian ^a   Cui, Rang Zhuang ^c   Zhao, Fu Mei ^c   Mao, Yong Min ^c   Li, Jing Yan ^a   Bi, Yan Yong ^a   Li, Hui ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b TIANJIN CHEST HOSPITAL   (China)

^c Tianjin Cardiovascular System Institute   (China)

Author keywords

Deep vein thrombosis; Gene polymorphism; Plasminogen activator inhibitor 1

Indexed keywords

PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE ANTIGEN; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; ALLELE; ARTICLE; CHINESE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; ETHNIC GROUP; FEMALE; GENE; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOTE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PROMOTER REGION; PROTEIN LOCALIZATION;

ADULT; AGED; CASE-CONTROL STUDIES; ELECTROPHORESIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PLASMINOGEN ACTIVATOR INHIBITOR 1; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; VENOUS THROMBOSIS;

EID: 29244472457     PISSN: 10039406     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Sartori MT, Danesin C, Saggiorato G, et al. The PAI1 gene 4G/5G polymorphism and deep vein thrombosis in patients with inherited thrombophilia. Clin Appl Thromb Hemost, 2003, 9:299-307.
2. Incalcaterra E, Hoffmann E, Averna MR, et al. Genetic risk factors in myocardial infarction at young age. Minerva Cardioangiol, 2004, 52:287-312.
3. Segui R, Estelles A, Mira Y, et al. PAI1 promoter 4G/5G genotype as an additional risk factor for venous thrombosis in subjects with genetic thrombophilic defects. Br J Haematol, 2000, 111:122-128.
4. Sartori TM, Wiman B, Vettore S, et al. 4G/5G polymoiphism PAI1 gene promoter and fibrinolytic capacity in patients with deep vein thrombosis. Thromb Haemost, 1998, 80:956-960.
5. Hooper WC, Lally C, Austin H, et al. The role of the t-PA I/D and PAI1 4G/5G polymorphisms in African-American adults with a diagnosis of myocardial infarction or venous thromboembolism. Thromb Res, 2000, 99:223-230.
6. Akar N, Yilmaz E, Akar E, et al. Effect of plasminogen activator inhibitor-1 4G/5G polymorphism in Turkish deep vein thrombotic patients with and without FV1691 G-A. Thromb Res, 2000, 97:227-230.
7. Varela ML, Adamczuk YP, Forastiero RR, et al. Major and potential prothrombotic genotypes in a cohort of patients with venous thromboembolism. Thromb Res, 2001, 104:317-324.
8. Eriksson P, Kallin B, Ferdinand M, et al. Allele-specific increase in basal transcription of the plasminogen activator inhibitor-1 gene is associated with myocardial infarction. Proc Natl Acad Sci U S A, 1995, 92:1851-1855.
9. Cushman M, Kuller LH, Prentice R, et al. Estrogen plus progestin and risk of venous thrombosis. JAMA, 2004, 292:1573-1580.
10. Kosch A, Junker R, Kurnik K, et al. Prothrombotic risk factors in children with spontaneous venous thrombosis and their asymptomatic parents: a family study. Thromb Res, 2000, 99:531-537.
11. Panahloo A, Mohamed-Ali V, Lane A, et al. Determinants of plasminogen activator inhibitor-1 activity in treated NIDDM and its relation to a polymorphism in the plasminogen activator inhibitor-1 gene. Diabetes, 1995, 44:37-42.
12. Folsom AR, Cushman M, Heckbert SR, et al. Prospective study of fibrinolytic markers and venous thromboembolism. J Clin Epidemiol, 2003, 56:598-603.
13. Dawson SJ, Wimans B, Hamsten A, et al. The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene respond differently to interleukin-1 in HepG2 cells. J Biol Chem, 1993, 268:10739-10745.